198 related articles for article (PubMed ID: 36802215)
1. Limosilactobacillus fermentum Limits Candida glabrata Growth by Ergosterol Depletion.
Zangl I; Beyer R; Gattesco A; Labuda R; Pap IJ; Strauss J; Schüller C
Microbiol Spectr; 2023 Feb; 11(2):e0332622. PubMed ID: 36802215
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-Function
Ollinger TL; Vu B; Murante D; Parker JE; Simonicova L; Doorley L; Stamnes MA; Kelly SL; Rogers PD; Moye-Rowley WS; Krysan DJ
mSphere; 2021 Dec; 6(6):e0083021. PubMed ID: 34935446
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus fermentum Ess-1 with unique growth inhibition of vulvo-vaginal candidiasis pathogens.
Rönnqvist D; Forsgren-Brusk U; Husmark U; Grahn-Håkansson E
J Med Microbiol; 2007 Nov; 56(Pt 11):1500-1504. PubMed ID: 17965352
[TBL] [Abstract][Full Text] [Related]
6. Antifungal Activity of Fibrate-Based Compounds and Substituted Pyrroles That Inhibit the Enzyme 3-Hydroxy-methyl-glutaryl-CoA Reductase of
Madrigal-Aguilar DA; Gonzalez-Silva A; Rosales-Acosta B; Bautista-Crescencio C; Ortiz-Álvarez J; Escalante CH; Sánchez-Navarrete J; Hernández-Rodríguez C; Chamorro-Cevallos G; Tamariz J; Villa-Tanaca L
Microbiol Spectr; 2022 Apr; 10(2):e0164221. PubMed ID: 35377226
[TBL] [Abstract][Full Text] [Related]
7. Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress.
Li QQ; Tsai HF; Mandal A; Walker BA; Noble JA; Fukuda Y; Bennett JE
Mol Med Rep; 2018 May; 17(5):6585-6597. PubMed ID: 29532896
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates.
Santos RB; Scorzoni L; Namba AM; Rossoni RD; Jorge AOC; Junqueira JC
Med Mycol; 2019 Apr; 57(3):391-394. PubMed ID: 29796666
[TBL] [Abstract][Full Text] [Related]
10. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
11. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
[TBL] [Abstract][Full Text] [Related]
12. Vaginal lactobacilli inhibit growth and hyphae formation of Candida albicans.
Jang SJ; Lee K; Kwon B; You HJ; Ko G
Sci Rep; 2019 May; 9(1):8121. PubMed ID: 31148560
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae.
Zavrel M; Hoot SJ; White TC
Eukaryot Cell; 2013 May; 12(5):725-38. PubMed ID: 23475705
[TBL] [Abstract][Full Text] [Related]
15. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
16. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
17. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
19.
Bautista-Crescencio C; Casimiro-Ramos A; Fragoso-Vázquez MJ; Correa-Basurto J; Olano C; Hernández-Rodríguez C; Villa-Tanaca L
Microbiol Spectr; 2023 Sep; 11(5):e0127123. PubMed ID: 37754674
[TBL] [Abstract][Full Text] [Related]
20. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
